The investment seeks long-term capital appreciation... Show more
The ERShares Private-Public Crossover ETF (XOVR) is an actively managed exchange-traded fund seeking long-term capital appreciation by investing primarily in U.S.-listed equity securities of mid- and large-cap companies exhibiting entrepreneurial leadership. Launched on November 7, 2017, and relaunched under its current name effective August 29, 2024, XOVR allocates at least 85% of assets to a rules-based public equity core aligned with the proprietary Entrepreneur 30 Total Return (ER30TR) Index. This index selects 30 large-cap U.S. stocks based on the Entrepreneur Factor® model, emphasizing management quality, innovation, growth potential, and stakeholder value creation across themes like AI, biotech, fintech, and space exploration.
The fund holds 33 positions, including a policy-capped sleeve of privately offered securities (e.g., SPV exposure to SpaceX LLC) for pre-IPO access, fair-valued daily into NAV. Top holdings as of late 2025 include SPV Exposure to SpaceX LLC (10.86%), NVIDIA Corp (10.31%), Meta Platforms Inc (5.24%), Maplebear Inc (4.11%), and Affirm Holdings Inc (3.66%). Sector allocations feature heavy weighting in information technology (34.76%), health care (14.64%), industrials (13.18%), financials (12.67%), and communication services (10.18%). The gross expense ratio is 0.75%, with portfolio turnover at 66% reflecting quarterly reconstitution of the ER30TR sleeve (~15-20% typical turnover). As a non-diversified ETF, it trades on NASDAQ with daily liquidity via creation/redemption in-kind.
XOVR captures the convergence of public markets and private venture capital, targeting the "pre-IPO economy" amid surging demand for innovation exposure. Structural growth drivers include accelerating tech adoption in AI, cloud computing, biotech, and space tech, fueled by macroeconomic tailwinds like declining rates and hyperscaler capex. Capital flows into entrepreneurial leaders have intensified, with VC dry powder exceeding $2 trillion globally, while regulatory easing on private valuations aids transparency.
Catalysts encompass earnings momentum in semiconductors and software, alongside geopolitical pushes for domestic supply chains in semiconductors and renewables. Risks involve valuation stretches in growth sectors, potential rate hike reversals squeezing multiples, and liquidity mismatches in private markets. Sector rotation toward industrials and financials amid infrastructure spending provides balance, but concentration in tech exposes to supply chain disruptions and antitrust scrutiny.
In recent market cycles, XOVR has navigated volatility through its concentrated innovation tilt, benefiting from rallies in AI and cloud leaders during earnings seasons while facing pressure from growth stock derating tied to rate expectations. The public core's alignment with ER30TR has captured upside in entrepreneurial outperformers amid sector rotation from mega-caps to mid-cap innovators, though private sleeve valuation adjustments have introduced NAV variability.
Over recent quarters, the fund has shown resilience in choppy environments, with quarterly rebalancing aiding positioning ahead of macro shifts like commodity rebounds supporting industrials. Heightened trading reflects investor interest in its crossover appeal, connecting broader thematic strength in disruptive tech to identifiable drivers like hyperscaler investments and biotech breakthroughs.
Tickeron’s Trending AI Robots page showcases the platform’s top-performing AI trading bots under prevailing market conditions. Tickeron provides hundreds of AI-driven bots scanning thousands of tickers across diverse strategies, timeframes, and performance metrics, from momentum and mean reversion to options and pattern recognition. Only the strongest current performers—often displaying win rates above 60% and average returns exceeding 20% over recent periods—earn a spot in this curated section. These bots adapt dynamically to volatility, sector shifts, and macro events, offering retail and institutional traders automated edges. Explore the page to identify bots aligning with your risk tolerance and market view, and consider integrating top performers into your strategy for enhanced decision-making.
Looking to 2026, XOVR’s positioning in entrepreneurial growth stocks positions it to benefit from sustained innovation cycles, particularly as AI infrastructure buildouts and biotech advancements drive earnings growth among top holdings. Structural drivers like U.S. policy support for semiconductors via CHIPS Act extensions and space commercialization could bolster sector exposures, while capital flows into VC-backed IPO pipelines may enhance private sleeve transitions.
Macro risks include persistent inflation prompting tighter policy, potentially compressing growth multiples, and geopolitical tensions disrupting supply chains in tech and industrials. Monitor earnings cycles for NVDA and peers, as beats could fuel rotations back to large-cap innovators. Competitive ETF landscape intensifies with thematic rivals, pressuring flows amid fee compression. Expense ratio stability at 0.75% remains competitive for active crossover strategies, but liquidity in private holdings warrants vigilance amid redemption pressures. Balanced sector diversification offers defense, with financials and industrials poised for rotation if economic resilience holds. Overall, track ER30TR quarterly rebalances for adaptability and private asset IPO catalysts for alpha potential.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where XOVR declined for three days, in of 285 cases, the price declined further within the following month. The odds of a continued downward trend are .
The 10-day RSI Indicator for XOVR moved out of overbought territory on June 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where XOVR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
XOVR broke above its upper Bollinger Band on June 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on June 15, 2026. You may want to consider a long position or call options on XOVR as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for XOVR just turned positive on June 16, 2026. Looking at past instances where XOVR's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOVR advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 265 cases where XOVR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows